Health knowledge made personal
Join this community!
› Share page:
Search posts:

Bristol-Myers Squibb Issues Voluntary Nationwide Recall of COUMADIN (Warfarin Sodium) for Injection Due to Presence of Particula

Posted Jul 01 2014 3:34pm
Bristol-Myers Squibb Company (NYSE:BMY) is voluntarily recalling six lots of COUMADIN FOR INJECTION, 5 mg single-use vials in the U.S. This recall is a precautionary measure based on the company's investigation of visible particulate matter found in a small number of COUMADIN FOR INJECTION unreleased samples.
Post a comment
Write a comment:

Related Searches